5,5-Dimethyloxazolidine-2,4-dione CAS 695-53-4
DMO; Nortrimethadione; Dimethadione; Eupractone ;
2,4-Oxazolidinedione, 5,5-dimethyl- ;
Mainly intermediate of epilepsy products
5,5-Dimethyloxazolidine-2,4-dione suppliers mentioned that in recent years, the treatment of epilepsy is still dominated by drug therapy. Quality has paid more attention to the safety of drug treatment. At present, the adverse reactions of antiepileptic drugs are increasingly concerned, and there are more and more research reports on the effects of antiepileptic drugs on emotional behavior.
5,5-Dimethyloxazolidine-2,4-dione manufacturers Epilepsy is a clinical syndrome caused by highly synchronized abnormal discharge of brain neurons. The rate of epilepsy patients with abnormal emotional behavior is significantly higher than that of the general population, which seriously affects the quality of life of patients. Emotional abnormalities in patients with epilepsy mainly include anxiety, depression, excitement, anger, etc., and behavioral changes often manifest as hyperactivity, impulsivity, irritability, paranoia, aggressive behavior, social problems, adaptive behavior disorders, violations of discipline, inattention, Internalization and externalization behavior problems, etc. There are many factors leading to abnormal emotional behavior of epilepsy patients, among which the influence of antiepileptic drugs is particularly concerned by the parents, caregivers and clinicians of the patients